HomeKEQU • NASDAQ
Kewaunee Scientific Corp
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Revenue | 67.17M | 43.59% |
Operating expense | 16.13M | 95.17% |
Net income | 1.35M | -46.29% |
Net profit margin | 2.02 | -62.52% |
Earnings per share | — | — |
EBITDA | 3.81M | -16.78% |
Effective tax rate | -8.47% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.45M | -55.64% |
Total assets | 189.15M | 49.75% |
Total liabilities | 127.03M | 56.90% |
Total equity | 62.12M | — |
Shares outstanding | 2.85M | — |
Price to book | 1.63 | — |
Return on assets | 3.48% | — |
Return on capital | 4.71% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jan 2025info | Y/Y change |
---|---|---|
Net income | 1.35M | -46.29% |
Cash from operations | -2.27M | -123.85% |
Cash from investing | -29.42M | -6,094.53% |
Cash from financing | 14.64M | 502.84% |
Net change in cash | -17.33M | -420.85% |
Free cash flow | -17.66M | -258.55% |
Previous close
$34.55
Day range
$32.05 - $34.59
Year range
$30.82 - $71.33
Market cap
94.88M USD
Avg Volume
28.63K
P/E ratio
5.62
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1906
Headquarters
Website
Employees
1,006